Alto Neuroscience(ANRO.US) Officer Sells US$3.57 Million in Common Stock

Exercising options at $2.35, Alto Neuroscience (ANRO)'s CFO sells shares.

Stock options underpin an officer's proposed share sale at Alto Neuroscience (NYSE: ANRO).

Alto Neuroscience Announces Participation in Upcoming Investor Conferences

Alto Neuroscience Promotes Nick Smith to President and Chief Financial Officer

Alto Neuroscience (ANRO) Reports Another Quarterly Loss, Is The Stock Already Overvalued?

Are Alto Neuroscience’s (ANRO) Rising Losses Funding a Stronger Depression Pipeline or Diluting Discipline?

Alto Neuroscience (ANRO) Stock Looks Stretched On Expanded ALTO 207 Plans

Why Alto Neuroscience (ANRO) Is Up 13.5% After Expanding ALTO-207 Phase 3 And Securing New Funding

Alto Neuroscience Announces Pricing of $100.0 Million Underwritten Registered Direct Offering of Common Stock

Is Alto Neuroscience, Inc. (ANRO) Stock Positioned for Growth With New Insights Into Anhedonia Treatment?

Alto Neuroscience Highlights Nature Medicine Publication Demonstrating Significant Effects of Pramipexole on Anhedonia

ANRO - Alto Neuroscience Inc Stock Price and Quote

ANRO Stock Drops 7% After Disappointing Schizophrenia Study Results – But Analyst Sees Dip As Attractive Entry Point

Alto Neuroscience Stock Pre-Market (-7.0%): Geopolitical Tensions Spark Risk-Off Move